Molecure Investor Relations Material
Latest events
Q4 2024
Molecure
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Molecure S A
Access all reports
Molecure S.A. is a biotechnology company focused on the discovery and development of small molecule therapies for the treatment of inflammatory and fibrotic diseases, as well as cancer. The company leverages its proprietary research platforms to identify novel drug targets and advance its pipeline of investigational treatments. The company is headquartered in Warsaw, Poland, and its shares are listed on the WSE.
Key slides for Molecure S A
Investor Presentation
Molecure S A
Investor Presentation
Molecure S A
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
MOC
Country
🇵🇱 Poland